A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy

Radiotherapy and Oncology

Volumn 111, Issue 1, 2014, Pages 114-119

  Roberts, Stephen A ^a   Miralbell, Raymond ^b,c   Zubizarreta, Eduardo H ^d   Fowler, Jack F ^e   Hendry, Jolyon H ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c Service of Radiation Oncology   (Spain)

^d INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^e Christie Medical Physics and Engineering Christie NHS Foundation Trust ^*  (United Kingdom)

^f CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Biochemical relapse free survival; High dose rate brachytherapy; Prostate cancer; Radiotherapy

Indexed keywords

ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOTHERAPY EQUIPMENT; RECURRENCE FREE SURVIVAL; COMPARATIVE STUDY; MALE; MULTICENTER STUDY; CLINICAL TRIAL; PROCEDURES; PROSTATIC NEOPLASMS; STATISTICAL MODEL;

BRACHYTHERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LINEAR MODELS; MALE; MODELS, STATISTICAL; PROSTATIC NEOPLASMS;

EID: 84902179954     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.01.008     Document Type: Article

References (27)

1. L. Aström, D. Pedersen, C. Mercke, S. Holmäng, and K.A. Johansson Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161
2. S. Aluwini, P.H. van Rooij, W.J. Kirkels, P.P. Jansen, J.O. Praag, and C.H. Bangma et al. High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience Int J Radiat Oncol Biol Phys 83 2012 1480 1485
3. S. Deger, D. Boehmer, J. Roigas, T. Schink, K.D. Wernecke, and T. Wiegel et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer Eur Urol 47 2005 441 448
4. D.J. Demanes, D. Brandt, L. Schour, and D.R. Hill Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation Am J Clin Oncol 32 2009 342 347
5. C. Vargas, A. Martínez, R. Galalae, J. Demanes, A. Harsolia, and L. Schour et al. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features Prostate Cancer Prostatic Dis 9 2006 245 253
6. P.J. Hoskin, A.M. Rojas, P.J. Bownes, G.J. Lowe, P.J. Ostler, and L. Bryant Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer Radiother Oncol 103 2012 217 222
7. A.C. Pellizzon, R.C. Fogaroli, M.L. Silva, D.G. Castro, M.C. Maia, and A. Lopes High-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for men with intermediate or high risk prostate cancer: analysis of short- and medium-term urinary toxicity and biochemical control Int J Clin Exp Med 4 2011 43 52
8. P.J. Prada, H. González, J. Fernández, I. Jiménez, A. Iglesias, and I. Romo Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 years of experience BJU Int 109 2012 1787 1793
9. D.R. Zwahlen, N. Andrianopoulos, B. Matheson, G.M. Duchesne, and J.L. Millar High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer Brachytherapy 9 2010 27 35
10. Y. Yoshioka, K. Konishi, I. Sumida, Y. Takahashi, F. Isohashi, and T. Ogata et al. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions Int J Radiat Oncol Biol Phys 80 2011 469 475
11. R. Miralbell, S.A. Roberts, E. Zubizarreta, and J.H. Hendry Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy Int J Radiat Oncol Biol Phys 82 2012 e17 e24
12. D.J. Brenner The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction Semin Radiat Oncol 18 2008 234 239
13. B.G. Douglas, and J.F. Fowler The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation Radiat Res 66 1976 401 426 [Reprinted: Radiat Res 2012;178:AV125-38]
14. M.C. Joiner Quantifying cell kill and cell survival M. Joiner, A.J. van der Kogel, Chapter 4 in: basic clinical radiobiology 2009 Hodder/Arnold London
15. J.Z. Wang, Z. Huang, S.S. Lo, W.T.C. Yuh, and N.A. Mayr A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose-rate brachytherapy Sci Transl Med 2 2010 39 48
16. E. van Rongen, H.D. Thames, and E.L. Travis Recovery from radiation damage in mouse lung: interpretation in terms of two rates of repair Radiat Res 133 1993 225 233
17. H.D. Thames Jr, H.R. Withers, and L.J. Peters Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair Br J Cancer Suppl 6 1984 263 269
18. M.C. Joiner, and S.M. Bentzen Fractionation: the linear-quadratic approach M. Joiner, A.J. van der Kogel, Chapter 8 in: basic clinical radiobiology 2009 Hodder/Arnold London
19. S.A. Roberts, and J.H. Hendry A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity Int J Radiat Oncol Biol Phys 41 1998 689 699
20. P. Pedicini, R. Caivano, L. Strigari, M. Benassi, A. Fiorentino, and V. Fusco In regard to Miralbell et al. Re: dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy Int J Radiat Oncol Biol Phys 85 2013 10 11
21. J.P. Kirkpatrick, J.J. Meyer, and L.B. Marks The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery Semin Radiat Oncol 18 2008 240 243
22. J.F. Fowler, W.A. Tomé, J.D. Fenwick, and M.P. Mehta A challenge to traditional radiation oncology Int J Radiat Oncol Biol Phys 60 2004 1241 1256 [Erratum in: Int J Radiat Oncol Biol Phys 2005;61:962]
23. B.L. Madsen, R.A. Hsi, H.T. Pham, J.F. Fowler, L. Esagui, and J. Corman Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results Int J Radiat Oncol Biol Phys 67 2007 1099 1105
24. D.J. Brenner, A.A. Martinez, G.K. Edmunsdon, C. Mitchell, H.D. Thames, and E.P. Armour Direct evidence that prostate tumors show high sensitivity. To fractionation (low α/β ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
25. W.A. Tomé, and J.F. Fowler On cold spots in tumor subvolumes Med Phys 29 2002 1590 1598
26. C. Ares, Y. Popowski, S. Pampallona, P. Nouet, G. Dipasquale, and S. Bieri et al. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study Int J Radiat Oncol Biol Phys 75 2009 656 663
27. R. Miralbell, M. Mollà, M. Rouzaud, A. Hidalgo, J.I. Toscas, and J. Lozano et al. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study Int J Radiat Oncol Biol Phys 78 2010 50 57